share_log

MAIA Biotechnology Analyst Ratings

MAIA Biotechnology Analyst Ratings

MAIA 生物技術分析師評級
Benzinga Analyst Ratings ·  2023/02/21 21:55
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
02/21/2023 209.05% Noble Capital Markets → $14 Initiates Coverage On → Outperform
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
02/21/2023 209.05% 來寶資本市場 →$14 開始承保 →跑贏大盤

What is the target price for MAIA Biotechnology (MAIA)?

Maia Biotech(Maia)的目標價是多少?

The latest price target for MAIA Biotechnology (AMEX: MAIA) was reported by Noble Capital Markets on February 21, 2023. The analyst firm set a price target for $14.00 expecting MAIA to rise to within 12 months (a possible 209.05% upside). 1 analyst firms have reported ratings in the last year.

Noble Capital Markets於2023年2月21日報道了Maia Biotech(美國證券交易所代碼:MAIA)的最新目標價。這家分析公司將目標價定為14美元,預計Maia將在12個月內上漲至(可能上漲209.05%)。1家分析公司在過去一年公佈了評級。

What is the most recent analyst rating for MAIA Biotechnology (MAIA)?

分析師對Maia Biotech(Maia)的最新評級是多少?

The latest analyst rating for MAIA Biotechnology (AMEX: MAIA) was provided by Noble Capital Markets, and MAIA Biotechnology initiated their outperform rating.

來寶資本市場對Maia Biotech(美國證券交易所股票代碼:MAIA)的最新分析師評級是由Noble Capital Markets提供的,Maia Biotech啟動了對其表現優於大盤的評級。

When is the next analyst rating going to be posted or updated for MAIA Biotechnology (MAIA)?

Maia Biotech(Maia)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MAIA Biotechnology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MAIA Biotechnology was filed on February 21, 2023 so you should expect the next rating to be made available sometime around February 21, 2024.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與Maia Biotech的高管和客戶交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Maia Biotech的上一次評級是在2023年2月21日提交的,所以你應該預計下一次評級將在2024年2月21日左右的某個時候提供。

Is the Analyst Rating MAIA Biotechnology (MAIA) correct?

分析師對Maia Biotech(Maia)的評級正確嗎?

While ratings are subjective and will change, the latest MAIA Biotechnology (MAIA) rating was a initiated with a price target of $0.00 to $14.00. The current price MAIA Biotechnology (MAIA) is trading at is $4.53, which is within the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的Maia Biotech(Maia)評級是以0.00美元至14.00美元的目標價啟動的。Maia Biotech(Maia)目前的交易價格為4.53美元,在分析師的預測範圍內。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論